I 7 SER 20 -11.893 -12.825
I 8 THR 0 -11.369 -10.062
I 9 ALA 9 -16.143 -15.321
I 10 LEU 13 -18.943 -18.260
I 11 ARG 3 -16.244 -14.721
I 12 GLU 12 -18.139 -17.433
I 13 LEU 30 -22.837 -23.661
I 14 ILE 14 -21.572 -20.702
I 15 GLU 6 -18.472 -17.038
I 16 GLU 17 -21.089 -20.619
I 17 LEU 27 -23.859 -24.220
I 18 VAL 9 -19.449 -18.248
I 19 ASN 13 -17.061 -16.594
I 20 ILE 27 -21.190 -21.858
I 21 THR 18 -19.183 -19.047
I 22 GLN 6 -14.259 -13.309
I 26 ALA 13 -12.872 -12.887
I 27 PRO 6 -15.068 -14.025
I 28 LEU 29 -20.568 -21.538
I 29 CYS 29 -19.829 -20.884
I 30 ASN 6 -15.077 -14.033
I 31 GLY 0 -13.736 -12.156
I 32 SER 21 -18.060 -18.398
I 33 MET 6 -19.145 -17.634
I 34 VAL 34 -21.852 -23.249
I 35 TRP 19 -19.905 -19.801
I 36 SER 12 -21.073 -20.029
I 37 ILE 21 -20.918 -20.928
I 38 ASN 7 -18.561 -17.232
I 39 LEU 24 -21.447 -21.740
I 40 THR 0 -17.221 -15.241
I 41 ALA 3 -16.952 -15.348
I 42 GLY 12 -18.752 -17.975
I 43 MET 20 -23.536 -23.129
I 44 TYR 18 -25.302 -24.463
I 45 CYS 10 -24.825 -23.120
I 46 ALA 18 -24.884 -24.092
I 47 ALA 35 -27.160 -28.062
I 48 LEU 21 -26.634 -25.986
I 49 GLU 20 -24.352 -23.852
I 50 SER 29 -25.225 -25.659
I 51 LEU 35 -26.594 -27.561
I 52 ILE 22 -24.013 -23.781
I 53 ASN 15 -21.032 -20.339
I 54 VAL 32 -22.182 -23.311
I 55 SER 5 -17.903 -16.419
I 56 GLY 5 -15.630 -14.408
I 57 CYS 26 -20.038 -20.724
I 58 SER 0 -18.368 -16.256
I 59 ALA 18 -21.145 -20.784
I 60 ILE 28 -23.849 -24.327
I 61 GLU 5 -21.287 -19.414
I 62 LYS 15 -21.138 -20.432
I 63 THR 34 -24.704 -25.773
I 64 GLN 21 -24.465 -24.066
I 65 ARG 7 -21.709 -20.017
I 66 MET 24 -22.410 -22.593
I 67 LEU 28 -25.026 -25.368
I 68 SER 13 -22.721 -21.603
I 69 GLY 15 -20.144 -19.553
I 70 PHE 27 -20.826 -21.536
I 71 CYS 23 -20.477 -20.767
I 72 PRO 2 -14.470 -13.036
I 73 HIS 10 -14.014 -13.553
I 74 LYS 3 -15.412 -13.985
I 75 VAL 25 -20.055 -20.623
I 76 SER 3 -17.577 -15.900
I 77 ALA 10 -16.714 -15.942
I 78 GLY 1 -13.826 -12.351
I 79 GLN 13 -13.062 -13.055
I 80 PHE 2 -11.766 -10.643
I 81 SER 24 -13.490 -14.699
I 82 SER 13 -10.160 -10.487
I 83 LEU 1 -8.840 -7.939
I 84 HIS 16 -10.622 -11.240
I 85 VAL 0 -7.287 -6.449
I 86 ARG 2 -6.740 -6.194
I 87 ASP 20 -12.340 -13.221
I 88 THR 7 -13.505 -12.757
I 89 LYS 7 -15.967 -14.936
I 90 ILE 18 -17.601 -17.647
I 91 GLU 11 -18.895 -17.987
I 92 VAL 28 -24.315 -24.738
I 93 ALA 10 -23.206 -21.687
I 94 GLN 12 -21.014 -19.978
I 95 PHE 33 -24.335 -25.331
I 96 VAL 33 -25.818 -26.644
I 97 LYS 12 -22.199 -21.026
I 98 ASP 23 -22.465 -22.526
I 99 LEU 40 -25.211 -26.912
I 100 LEU 19 -23.182 -22.701
I 101 LEU 8 -19.772 -18.418
I 102 HIS 20 -19.547 -19.599
I 103 LEU 28 -21.905 -22.606
I 104 LYS 10 -17.696 -16.811
I 105 LYS 10 -14.139 -13.663
I 106 LEU 22 -15.731 -16.452
I 107 PHE 15 -13.595 -13.756
I 108 ARG 6 -10.811 -10.258
I 109 GLU 7 -10.861 -10.417
I 110 GLY 0 -10.882 -9.631

Identified 0 B-Cell epitope residues out of 101 total residues